FDA Panel Approves Kybella for Cosmetic Usage
A new cosmetic treatment for double chins is predicted to be more popular than Botox or Liposuction. Known as the "Double Chin Shot," the procedure involves the injection of a newly approved treatment called Kybella (deoxycholic acid) which mimics a fat-dissolving chemical already found in the human body. Given that the procedure can be done on an outpatient basis, and at a limited cost, there may be a strong demand from those who want to remove fat from the facial and neck area.
Licensed health care professionals and cosmetic surgeons are expected to be the top sources of the double chin injection once it becomes widely available. Regulations may vary on a state to state basis, and like any other procedure, even one which takes a few seconds and is done on an outpatient basis, it is important to go to a medical professional with a solid reputation.
Will Kybella parties replace Botox parties? The jury is out, but there is the thought that a lot more people are concerned about the shape of their faces than are worried about wrinkles, though there would certainly be a synergy among those who are concerned about their appearance to the extent that they visit their clinics on a regular basis. The difference, of course, is that one treatment paralyzes you facial muscles and pulls out wrinkles while the other removes the pressure of fatty cells beneath the surface. In either instance, you need to be sure you are going to get the results that you paid for, and be reasonably sure that you are not going to experience a look that improves your overall appearance. There are people who have injections into their lips and other areas in order to get a bigger and fuller look, and the fat cells in your face may be conspicuous in their absence if they are suddenly not there. Then again, you are already in touch with a cosmetic surgeon so there could be further enhancements under the umbrella of services provided.
Other Fat-Reducing Potential?
Currently the fat-reducing potential of Deoxycholic acid is limited to the chin area because it would take a great deal more to reduce fat deposits on other parts of the body. In fact, the FDA only approves it for that part of the body. While there may be some small spots where the drug would be useful, the chief application for the treatment now will naturally be in the face and neck. Although double chins are most often associated with being overweight, age and other factors may create deposits of fatty tissue in the head and neck, so otherwise fit people may be looking to slim down their profiles and adjust their sillhouettes.
Side Effects
Side effects of the double chin shot can include bruising, pain, and swelling around the injection site. Some briefly reported trouble swallowing. Additionally, there are a number of injections in each treatment (up to fifty) and the treatments can be 30 days or more apart, so there can always be some natural residual pain from the injections themselves.
According to news reports the double chin treatment will be available after training for medical providers who will be administering the treatment. It could take some months after the June 2015 release date for the Kybella shot to be widely available in all areas.
Kybella, the double-chin injection approved by the FDA, is sold in holographic packages to licensed and trained medical doctors. The manufacturer, Kythera Biopharmaceuticals Incorporated, is at the present time the only approved source of the treatment. The dispensing packages have unique holograms on the label of the vials used for treatment. The Food and Drug administration also cautions that potential patients should be fully cognizant of the risks related to using deoxycholic acid and the potential side effects.